• Return to Headlines

Adamas Pharmaceu Shares Down 37.6% Since SmarTrend's Sell Call (ADMS)

By Nick Russo

SmarTrend identified a Downtrend for Adamas Pharmaceu (NASDAQ:ADMS) on March 6th, 2019 at $8.08. In approximately 3 months, Adamas Pharmaceu has returned 37.59% as of today's recent price of $5.04.

In the past 52 weeks, Adamas Pharmaceu share prices have been bracketed by a low of $4.46 and a high of $29.49 and are now at $5.04, 13% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 2.4% while the 50-day MA has declined 3.1%.

Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company develops drugs to improve the lives of those affected by chronic disorders of the central nervous system. Adamas Pharmaceuticals seeks to achieve this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Adamas Pharmaceu.

Log in and add Adamas Pharmaceu (ADMS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights adamas pharmaceu

Ticker(s): ADMS